Founded in 2015, leadXpro AG is a rapidly growing biotech company focusing on solving structures of membrane protein drug targets (e.g. GPCRs, ion-channels and transporters) for the discovery and optimization of next-generation medicines. leadXpro characterizes the interaction of candidate molecules with drug targets to impact the discovery of novel therapeutics. To know more
